Innate Pharma announced that Sonia Quaratino, EVP Chief Medical Officer, will participate in a panel discussion titled "Changing Treatment Landscape in Bladder Cancer" at the BTIG Virtual Biotechnology Conference. The event is scheduled for July 28, 2026, at 10:30 a.m. EDT. Innate Pharma is a clinical-stage biotechnology company developing immunotherapies for cancer patients.
